Peter Clark, MD, discusses key updates to NMIBC guidelines, including revisions to risk stratification, the emerging role of biomarkers, and how to navigate treatment options for BCG-unresponsive disease.
|Podcasts|February 23, 2022
Destigmatizing Urology: Dr. Justin Dubin discusses testosterone deficiency
Author(s)Urology Times staff
“We need to create this safe, comfortable, welcoming environment for men to talk about the things that they need to talk about,” says Justin Dubin, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Justin Dubin, MD. He discusses perceived masculinity as a major barrier for men who need care for testosterone deficiency. He also discusses how urologists can create a more supportive environment for this reluctant population of patients. Dubin is an andrology fellow at Northwestern University in Chicago, Illinois.
Advertisement
Related to this article
Heather Florio joins to discuss the potential role of supplements in pelvic and sexual health.
Pearls & Perspectives: Expanding Sexual Health Conversations Through Digital Media, With Wendy Brant
Amy Pearlman, MD, and Wendy Brant discuss building a digital audience, navigating sexual health content online, and the role of communication in relationships.
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
Marian Cuello joins to discuss sexual wellness and the importance of normalizing conversations about sexual health for all individuals.
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD
2
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
3
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
4
Closing Risk Stratification Gaps in Localized Prostate Cancer With AI
5